VesugenВезуген
What is it?
A short peptide containing three amino acids, listed in the 2013 bioregulator catalogue in connection with vascular function. This is a research target, not an established treatment benefit.
Identity / background source ↗
Research context
The occupational report names Pinealon and Vezugen in combination. The accessible abstract does not isolate Vesugen’s contribution or establish safer driving.
- Working classification
- Bioregulator
- Research collection
- Peptide bioregulation · editorial grouping
- Institutional provenance
- Not established for this compound record
- Last evidence review
- Full evidence review pending; source-check scope appears with each publication below.
What do we know?
- Human research
- —Combination report
- Study methods
- —Abstract-level review
- Independent replication
- —Not assessed
- Source access
- —English abstract
- Safety evidence
- —Not assessed
These are independent review fields, not a rating. Missing evidence in this starter does not mean no research exists.
Linked sources
Explore the research map and unresolved leads ↗
Mechanism of Biological Activity of Short Peptides: Cell Penetration and Epigenetic Regulation of Gene Expression
V. Kh. Khavinson, A. Yu. Solovyev, S. I. Tarnovskaya, N. S. Linkova · Biology Bulletin Reviews 3(6):451–455
Mechanistic review with a table of 15 short peptides on page 453. Tissue labels in the research map are the authors’ proposed targets, not established clinical indications.
- Population / setting
- Review of earlier research
- What was checked
- Author-hosted English PDF and its peptide table checked. Each cited experiment remains a separate appraisal task.
Limitations & review scope
- Source-linked does not mean a completed risk-of-bias review.
- A review is not an independent clinical replication; proposed mechanisms do not establish efficacy or safety.
Source checked 2026-09-27. This is a source-linked record, not a completed evidence review.
The peptide correction of neurotic disorders among professional truck-drivers
A. S. Bashkireva, V. G. Artamonova · Adv Gerontol. 25(4):718–728
The abstract describes occupational psychoemotional differences and reports changes with peptide bioregulators, including combined Pinealon and Vezugen.
- Population / setting
- 150 male lorry drivers and 150 male metal craftsmen in the occupational comparison
- What was checked
- PubMed record and English abstract checked; intervention allocation and full methods not reviewed.
Limitations & review scope
- The occupational cohort size is not a verified randomized-treatment sample size.
- Randomization, blinding, and intervention-group sizes are not established from the abstract.
- Combination findings do not identify either peptide’s independent contribution or demonstrate fewer driving accidents.
Source checked 2026-09-27. This is a source-linked record, not a completed evidence review.
Explore related historical combinations ↗
Browse bibliography & PDFs ↗